It was suggested [144] that IL-6 levels in tumour-associated endothelial cells correlate with the tumourigenicity of CSCs, as evidenced in vitro by the p-STAT3 activation, survival, and self-renewal of human CSCs. The gene discussed is STAT3; the disease is neoplasm.